Bradac GB - Search Results

1

Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function.

Durelli L, Bongioanni MR, Cavallo R, Ferrero B, Ferri R, Verdun E, Bradac GB, Riva A, Geuna M, Bergamini L, et al. Durelli L, et al. Among authors: bradac gb. Mult Scler. 1995;1 Suppl 1:S32-7. Mult Scler. 1995. PMID: 9345396 Clinical Trial.

2

Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis.

Durelli L, Bongioanni MR, Cavallo R, Ferrero B, Ferri R, Ferrio MF, Bradac GB, Riva A, Vai S, Geuna M, et al. Durelli L, et al. Among authors: bradac gb. Neurology. 1994 Mar;44(3 Pt 1):406-13. doi: 10.1212/wnl.44.3_part_1.406. Neurology. 1994. PMID: 8145906 Clinical Trial.

3

Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatment.

Durelli L, Bongioanni MR, Ferrero B, Ferri R, Imperiale D, Bradac GB, Bergui M, Geuna M, Bergamini L, Bergamasco B. Durelli L, et al. Among authors: bradac gb. Neurology. 1996 Jul;47(1):123-9. doi: 10.1212/wnl.47.1.123. Neurology. 1996. PMID: 8710065 Clinical Trial.

4

Long term recombinant interferon alpha treatment in MS with special emphasis to side effects.

Durelli L, Bongioanni MR, Ferrero B, Imperiale D, Verdun E, Oggero A, Gentile E, Bradac GB, Bergui M, Bergamini L, Bergamasco B. Durelli L, et al. Among authors: bradac gb. Mult Scler. 1996 Jul;1(6):366-71. doi: 10.1177/135245859600100617. Mult Scler. 1996. PMID: 9345419 Clinical Trial.

5

Interferon-beta dose and efficacy: the OPTIMS study.

Durelli L, Oggero A, Verdun E, Barbero P, Pipieri A, Isoardo G, Ricci A, Clerico M, Bradac G, Bergamasco B, Bergui M. Durelli L, et al. Neurol Sci. 2001 Apr;22(2):201-3. doi: 10.1007/s100720170024. Neurol Sci. 2001. PMID: 11603627

6

[Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].

Bradac GB, Riva A, Berger T, Stura G, Duca S. Bradac GB, et al. Radiol Med. 1988 Jul-Aug;76(1-2):33-7. Radiol Med. 1988. PMID: 3399707 Italian.

7

Autosomal dominant late-onset leukoencephalopathy. Clinical report of a new Italian family.

Quattrocolo G, Leombruni S, Vaula G, Bergui M, Riva A, Bradac GB, Bergamini L. Quattrocolo G, et al. Among authors: bradac gb. Eur Neurol. 1997;37(1):53-61. doi: 10.1159/000117406. Eur Neurol. 1997. PMID: 9018034 Review.

8

Primary cerebellar and spino-cerebellar ataxia an MRI study on 63 cases.

Riva A, Bradac GB. Riva A, et al. Among authors: bradac gb. J Neuroradiol. 1995 Jun;22(2):71-6. J Neuroradiol. 1995. PMID: 7629572

9

Superficial siderosis of the central nervous system: neuroradiological evaluation of two cases.

Daniele D, Bracchi M, Riva A, Duca S, Stura G, Bradac GB. Daniele D, et al. Among authors: bradac gb. Eur Neurol. 1992;32(5):270-3. doi: 10.1159/000116840. Eur Neurol. 1992. PMID: 1521549

10

Diffusion-weighted MR in reversible wernicke encephalopathy.

Bergui M, Bradac GB, Zhong JJ, Barbero PA, Durelli L. Bergui M, et al. Among authors: bradac gb. Neuroradiology. 2001 Nov;43(11):969-72. doi: 10.1007/s002340100645. Neuroradiology. 2001. PMID: 11760803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters